This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Efatutazone

Daiichi Sankyo Co., Ltd.

Drug Names(s): Efatutazone, C64764, CS7017, CS-7017

Description: CS-7017 is a novel thiazolidinedione class peroxisome proliferator-activated receptor gamma (PPARgamma) agonist. CS-7017 activated PPARgamma-mediated luciferase expression and shown to be highly selective for PPARgamma amongst other PPAR subfamilies. CS-7017 inhibited the proliferation of the human anaplastic thyroid tumour cell line DRO and the pancreatic tumour cell line AsPC-1 in vitro.


Efatutazone News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug